REZUROCK

belumosudil · Kadmon Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for REZUROCK, covering 2021-07-16 to 2026-08-25. Get the full timeline:

Most recent: EMA Authorised: Rezurock (belumosudil mesilate) — Sanofi Winthrop Industrie